eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2024
vol. 41
 
Share:
Share:
abstract:
Original paper

Rationale for the topical use of a combination of diphenhydramine hydrochloride and lidocaine hydrochloride in the symptomatic treatment of histamine-dependent allergic and inflammatory skin reactions, accompanied by pruritus

Zbigniew Doniec
1, 2
,
Małgorzata Sielska
3
,
Tomasz Wróbel
3
,
Roman J. Nowicki
4

  1. National Research Institute for Tuberculosis and Lung Diseases, Rabka Branch, Rabka, Poland
  2. Medical Institute, Academy of Applied Science, Nowy Targ, Poland
  3. Research and Development Centre Novasome Sp. z o.o., Wroclaw, Poland
  4. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland
Adv Dermatol Allergol 2024; XLI (4): 388-394
Online publish date: 2024/06/30
View full text Get citation
 
Introduction:
Allergic reactions caused by external factors are treated with medicinal products containing antihistamines, therefore their action is delayed in time. Combination of antihistamines and fast-acting analgesics may help to reduce discomfort associated with cutaneous reactions.

Aim:
To evaluate efficacy and safety of the combination topical gel containing diphenhydramine hydrochloride 20 mg/g and lidocaine hydrochloride 10 mg/g over placebo in the treatment of local skin inflammatory and allergic reactions.

Material and methods:
A study was a single-centre, single-dose, randomized, double-blind, two-treatment, two-period, two-sequence cross-over clinical trial (n = 44) in healthy subjects. Local skin inflammatory and allergic lesions were induced by the provocative test with histamine in healthy subjects. For all parameters recorded with the Visual Analogue Scale (VAS), the area under the curve (AUC) was calculated and the peak itch intensity was noted for every subject in response to the skin prick test. The primary endpoint of the study was the difference in AUC calculated from the intensity of itch for test product A (diphenhydramine hydrochloride 20 mg/g and lidocaine hydrochloride 10 mg/g, gel) and placebo product B.

Results:
The results revealed that itching intensity AUC was significantly greater for product B than for product A, on average by 2.05 points. A decrease in itching intensity was observed from the second minute after application of the test product.

Conclusions:
The study provided evidence for differences in efficacy between the product tested and placebo.

keywords:

diphenhydramine, lidocaine, pruritus, oedema, allergic reaction

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.